期刊： TRANSPLANTATION REVIEWS, 2021; 35 (2)
Liver transplantation (LT), one of the radical methods of treating liver cancer, has brought new hope for the treatment of unresectable liver cancer. ......
期刊： TRANSPLANTATION REVIEWS, 2021; 35 (3)
Background: The effect of solid organ transplantation (SOT) on the severity and mortality of coronavirus disease 2019 (COVID-19) remained controversia......
期刊： TRANSPLANTATION REVIEWS, 2021; 35 (2)
Orthotopic liver transplantation (OLT) is a well-established treatment for patients with liver failure. The shortage of donor organs and postoperative......
期刊： TRANSPLANTATION REVIEWS, 2021; 35 (1)
Kidney transplantation is the preferred treatment for patients with end-stage renal disease. However, various types of kidney graft injury after trans......
期刊： TRANSPLANTATION REVIEWS, 2021; 35 (1)
Background-objectives: Liver transplantation (LT) and combined liver and kidney transplantation (CLKT) have been proposed as enzyme replacement therap......
期刊： TRANSPLANTATION REVIEWS, 2020; 34 (3)
Lung transplantation (LTx) is the only therapeutic option for end-stage lung diseases. Chronic lung allograft dysfunction (CLAD), which manifests as a......
期刊： TRANSPLANTATION REVIEWS, 2018; 32 (4)
B cells play a crucial role in alloreactivity of organ transplant rejection and graft versus host diseases (GVHD). Over the past decade, it has been w......
期刊： TRANSPLANTATION REVIEWS, 2017; 31 (3)
Background: Splenic steal syndrome (SSS) is a condition that can occur after orthotopic liver transplant (OLT). However, limited information is availa......
期刊： TRANSPLANTATION REVIEWS, 2022; 36 (4)
Long-term immunosuppressant use in renal transplant recipients leads to dampened immune function and high susceptibility to opportunistic pathogens. R......
期刊： TRANSPLANTATION REVIEWS, 2022; 36 (1)
Background: Data on predictors of post-recurrence survival (PRS) of recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) have not......
期刊： TRANSPLANTATION REVIEWS, 2022; 36 (4)
Background: Treatment for de novo or recurrent tumors of liver transplantation (LT) recipients is challenging and immune checkpoint inhibitor (ICI) is......
